Probiotics

Over 20 years ago our Microbial Fermentation Unit (MFU) began screening over 2000 bacterial strains to identify potential probiotics.

Through vigorous testing and extensive research, we have selected the best strains for commercialisation.

This extensive process led to the discovery of LactoB 001 isolated from a New Zealand cheddar cheese culture, and BifidoB 019 from a yoghurt culture.

NZMP's probiotic strains tick all the boxes to give customers confidence about:

• Safety: Our strains have US FDA GRAS status, and well-established history of use, with studies showing no adverse side effects.

• Stability: Our strains can survive the harsh conditions of the human gastrointestinal tract. Our proprietary manufacture techniques deliver specs with high survival rates. This provides customers with shelf-life advantages and ensures our probiotics reach consumers in a viable state to deliver health benefits.

• Effectiveness: We have scientific evidence across in vitro and in vivo studies (both animal and human research) which clinically document various health benefits. The quality of our studies is recognised in over 80 peer-reviewed publications.